WST in the 13F filings
West Pharmaceutical SVSC Inc · CUSIP 955306105
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 9 Aug 2024
- Managers listing it
- 14
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 11 listed it in both
- Shares listed
- 9,568,187
- combined, among listed positions
- Reported value
- $3.2bn
- combined, at the quarter end
Among the 94 comparable managers: 9 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing WST in Q2 2024
14 of 14 holders
Largest increases and reductions, by shares
Increases
- AllianceBernstein LPexisting position · 2,229,215 shares now+1,602,293
- Artisan Partners LPexisting position · 2,491,892 shares now+425,355
- Voloridge Investment Management LLCnew position · 57,690 shares now+57,690
- ExodusPoint Capital Management LPexisting position · 48,945 shares now+17,034
- Moore Capital Management LPexisting position · 80,000 shares now+15,000
Reductions
- T. Rowe Price Associates Incexisting position · 1,693,827 shares now-339,063
- Holocene Advisors LPexisting position · 186,133 shares now-170,875
- Millennium Management LLCexisting position · 393,857 shares now-122,769
- MFS Investment Managementexisting position · 636,573 shares now-88,644
- Neuberger Berman Group LLCexisting position · 420,604 shares now-67,730
New positions and exits
New (1)
Exited (2)
- Woodline Partners LPwas $66m
- Maverick Capital Ltdwas $393k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 3 | $230m | n.a. | n.a. |
| Q3 2013 | 4 | $290m | n.a. | n.a. |
| Q4 2013 | 5 | $370m | n.a. | n.a. |
| Q1 2014 | 4 | $348m | n.a. | n.a. |
| Q2 2014 | 4 | $344m | n.a. | n.a. |
| Q3 2014 | 3 | $349m | n.a. | n.a. |
| Q4 2014 | 3 | $403m | n.a. | n.a. |
| Q1 2015 | 4 | $757m | n.a. | n.a. |
| Q2 2015 | 4 | $795m | n.a. | n.a. |
| Q3 2015 | 4 | $798m | n.a. | n.a. |
| Q4 2015 | 4 | $896m | n.a. | n.a. |
| Q1 2016 | 4 | $1.0bn | n.a. | n.a. |
| Q2 2016 | 6 | $1.0bn | n.a. | n.a. |
| Q3 2016 | 7 | $1.1bn | n.a. | n.a. |
| Q4 2016 | 7 | $1.4bn | n.a. | n.a. |
| Q1 2017 | 8 | $1.3bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.4bn | n.a. | n.a. |
| Q3 2017 | 5 | $1.4bn | n.a. | n.a. |
| Q4 2017 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.5bn | n.a. | n.a. |
| Q2 2018 | 8 | $1.7bn | n.a. | n.a. |
| Q3 2018 | 11 | $2.1bn | n.a. | n.a. |
| Q4 2018 | 10 | $1.7bn | n.a. | n.a. |
| Q1 2019 | 14 | $2.0bn | n.a. | n.a. |
| Q2 2019 | 12 | $2.2bn | n.a. | n.a. |
| Q3 2019 | 20 | $2.6bn | n.a. | n.a. |
| Q4 2019 | 12 | $2.4bn | n.a. | n.a. |
| Q1 2020 | 19 | $2.3bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.2bn | n.a. | n.a. |
| Q3 2020 | 20 | $3.8bn | n.a. | n.a. |
| Q4 2020 | 18 | $3.9bn | n.a. | n.a. |
| Q1 2021 | 15 | $3.6bn | n.a. | n.a. |
| Q2 2021 | 16 | $4.9bn | n.a. | n.a. |
| Q3 2021 | 21 | $5.9bn | n.a. | n.a. |
| Q4 2021 | 18 | $6.8bn | n.a. | n.a. |
| Q1 2022 | 20 | $6.3bn | n.a. | n.a. |
| Q2 2022 | 19 | $4.4bn | n.a. | n.a. |
| Q3 2022 | 23 | $2.9bn | n.a. | n.a. |
| Q4 2022 | 20 | $2.2bn | n.a. | n.a. |
| Q1 2023 | 19 | $3.9bn | n.a. | n.a. |
| Q2 2023 | 19 | $4.1bn | n.a. | n.a. |
| Q3 2023 | 20 | $4.3bn | n.a. | n.a. |
| Q4 2023 | 16 | $3.5bn | 7 | 10 |
| Q1 2024 | 17 | $4.1bn | 12 | 7 |
| Q2 2024 | 14 | $3.2bn | 9 | 7 |
| Q3 2024 | 14 | $2.9bn | 9 | 5 |
| Q4 2024 | 17 | $3.0bn | 11 | 8 |
| Q1 2025 | 12 | $1.4bn | 9 | 4 |
| Q2 2025 | 13 | $1.3bn | 12 | 3 |
| Q3 2025 | 13 | $2.1bn | 12 | 2 |
| Q4 2025 | 16 | $1.6bn | 25 | 14 |
| Q1 2026 | 12 | $1.3bn | 21 | 20 |
| Q2 2026 | 12 | $3.1bn | 15 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
WST and LLY →WST and JNJ →WST and VRTX →Choose a stock to compare with WST →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own WST, latest filings →Back to the 13F Explorer →